Neal Kumar
Overview
Explore the profile of Neal Kumar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qualkenbush E, Perry A, Kumar N, Thomas C, Pak R, Hemal S, et al.
Urology
. 2024 Sep;
196:1-8.
PMID: 39307432
Objective: To determine the utility of a virtual reality (VR) model constructed using patient-derived clinical imaging to improve patient understanding of localized prostate cancer (PCa) diagnosis and surgical plan. Methods:...
2.
du Crest D, Garibyan L, Haedersdal M, Zink A, Madhumita M, Harth Y, et al.
Dermatologie (Heidelb)
. 2023 Aug;
74(11):899-903.
PMID: 37550513
No abstract available.
3.
Fields J, Alturkistani T, Kumar N, Kanuri A, Salem D, Munn S, et al.
Clinicoecon Outcomes Res
. 2015 Jun;
7:281-6.
PMID: 26082653
Objective: To quantify the type, prevalence, and cost of imaging following inpatient falls, identify factors associated with post-fall imaging, and determine correlates of positive versus negative imaging. Design: Single-center retrospective...
4.
Kumar N, Narang K, Cressey B, Gottlieb A
Expert Opin Drug Saf
. 2013 Jun;
12(5):757-65.
PMID: 23745965
Introduction: The biologic, Ustekinumab (Stelara®, Centocor, Inc., Malvern, PA, USA), is a fully human monoclonal antibody with a high affinity for the shared p40 subunit of interleukins 12 and 23...
5.
Kumar N, Goldminz A, Kim N, Gottlieb A
BMC Med
. 2013 Apr;
11:96.
PMID: 23557064
Advancements in phosphodiesterase (PDE)-targeted therapies have shown promise in recent years for treating patients with a variety of autoimmune diseases. This review summarizes the development of PDE4 inhibitors and the...
6.
Cressey B, Kumar N, Scheinman P
Dermatitis
. 2012 Jul;
23(4):158-61.
PMID: 22828254
Background: Sorbitan sesquioleate (SSO), an emulsifier in many corticosteroids, was previously found positive in 8.9% of 112 dermatitis patients. Objective: The objective of this study was to present data on...